Form 4 Tracker
Mark Ragosa

CHIEF FINANCIAL OFFICER · 5 filings · Latest: Sep 1, 2026

Kiniksa Pharmaceuticals International, plc
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
KNSA
Mark RagosaCHIEF FINANCIAL OFFICERSep 1, 2026
Option Exercise
—9,104—25,258
KNSA
Mark RagosaCHIEF FINANCIAL OFFICERApr 7, 2026
Option Exercise
—2,694—17,457
KNSA
Mark RagosaCHIEF FINANCIAL OFFICERApr 1, 2026
Option Exercise
—5,187—17,273
KNSA
Mark RagosaCHIEF FINANCIAL OFFICERMar 9, 2026
Sale
$45.9236,722$1.7M12,086
KNSA
Mark RagosaCHIEF FINANCIAL OFFICERMar 9, 2026
Option Exercise
$20.6936,722$759.8K48,808
KNSA
Ragosa Mark—Mar 9, 2026
Proposed Sale
$45.9236,722$1.7M—
KNSA
Mark RagosaCHIEF FINANCIAL OFFICERFeb 9, 2026
Sale
$43.2817,845$772.3K12,086
KNSA
Mark RagosaCHIEF FINANCIAL OFFICERFeb 9, 2026
Option Exercise
$13.8710,845$150.4K29,931
KNSA
Ragosa Mark—Dec 8, 2025
Proposed Sale
$41.4972,686$3.0M—
KNSA
Ragosa Mark—Oct 28, 2025
Proposed Sale
$41.0020,000$820.0K—
KNSA
Ragosa Mark—Oct 28, 2025
Proposed Sale
$41.0020,000$820.0K—
KNSA
Ragosa Mark—Aug 4, 2025
Proposed Sale
$32.8918,889$621.3K—
KNSA
Ragosa Mark—Jun 3, 2025
Proposed Sale
$28.8018,299$527.0K—
KNSA
Ragosa Mark—May 1, 2025
Proposed Sale
$27.8025,141$698.9K—
KNSA
Ragosa Mark—Apr 30, 2025
Proposed Sale
$26.9521,254$572.8K—
KNSA
Ragosa Mark—Apr 29, 2025
Proposed Sale
$25.6142,000$1.1M—
KNSA
Ragosa Mark—Mar 17, 2025
Proposed Sale
$23.1036,287$838.2K—
KNSA
Ragosa Mark—Mar 12, 2025
Proposed Sale
$22.2536,372$809.4K—
KNSA
Ragosa Mark—Dec 3, 2024
Proposed Sale
$21.2572,754$1.5M—